94

Volume 15 No. 4 December 2009 -SAJP
that depression is associated with an increased risk of transition to psychotic disorder, and that psychotic-like experiences reduce concurrently with an improvement in depression. 9 Schizophrenia represents a heterogeneous patient population.
Studying a distinct homogeneous subgroup therefore offers the advantage of reducing the influence of the heterogeneousness on the variability of prevalence of depression in schizophrenia.
Studies 10, 11 have reported that depressive symptoms are less frequent in schizophrenia patients in the chronic period than in the acute period. The prevalence of depressive symptoms is lower in patients suffering from one proposed subgroup of chronic schizophrenia, Kraepelinian schizophrenia, compared with published data on non-Kraepelinian chronic patients.
11
Kraepelinian schizophrenia is characterised by a chronic course of illness and severe deterioration of functioning in social, work and self-care domains. The Kraepelinian subgroup of schizophrenic patients is defined as having been totally dependent on others for the provision of necessities such as food, clothing and shelter for at least the previous 5 years. 12 The differences between Kraepelinian and non-Kraepelinian subtypes have been described by Roy et al. 13 The Kraepelinian subtype is characterised by an unremitting and severe course and the non-Kraepelinian subtype by a remitting course and periods of self-care. The Kraepelinian group has more impairment on neuropsychological testing, more severe negative and positive symptoms, less severe depressive symptoms and relative nonresponsiveness to treatment with haloperidol.
Neuro-imaging studies have also been used to compare the two subgroups. Kraepelinian subtype patients were characterised by lower metabolic rates in the temporal lobe and cingulate gyrus and lower fronto/occipital ratios than non-Kraepelinian patients.
Kraepelinian patients have greater left-sided structural brain abnormalities than non-Kraepelinian patients.
14 Exploratory statistical probability mapping also revealed lower metabolic rates in the right striatum in Kraepelinian versus nonKraepelinian patients. Differences in age, symptom severity, or severity of involuntary movements could not explain these differences.
14
Objective
The objective of this study was to investigate the prevalence of depressive symptoms, assessed using the Calgary Depression Scale for Schizophrenia (CDSS), in a relatively homogeneous group of chronically institutionalised patients with Kraepelinian schizophrenia. The researchers used the CDSS because of its discriminate validity. The CDSS evaluates depressive symptoms independently from the disease phase in this subject population.
In addition, the researchers used the Clinical Global Impression Severity (CGI-S) scale to investigate whether depressive symptoms were significantly associated with the severity of the illness.
Method
All hospitalised patients in the long-term wards of Weskoppies 
Results
Demographic details on the patients are set out in Table I 
Discussion
In this study, less than a fifth of patients with Kraepelinian schizophrenia patients had a significantly high CDSS score (≥5).
Kilzieh et al. 12 found that only 5% of their patients scored 16
or more on the HDRS. A difference in the thresholds of the two different scales for the presence of depression may be a plausible explanation for the different findings -a score of 16 on the HDRS seems at clinical face value to be a higher threshold than a 5 on the CDSS.
In a study by Rocca et al., 23 male gender was associated with an increased severity of depressive symptoms. Our study also indicated that a slightly higher proportion of male patients than females suffered from depression.
Our research found no statistically significant association between severity of illness (measured by the CGI-S scale) and the presence of depression, which is consistent with previous studies.
12,24
Liddle et al. 24 suggest that depression may be related to the psychopathology of the subjective experience of schizophrenia in two ways, namely the 'psychological' and the 'neural mechanism'. According to the 'psychological mechanism', the subjective experience of deficits may be a predisposing condition for depression, which would arise as an understandable expression of the awareness of the loss of normal mental function.
The distress associated with 'deficit awareness' is due to the insight of the practical constraints brought about by these deficits.
Limitations of the study include the following:
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Conclusion
This study confirmed results from previous studies that less than a fifth of patients with Kraepelinian schizophrenia suffer from depression, in spite of having moderate clinical global impairment.
Further studies are needed that include correlation analyses between depression and positive and negative symptoms in both
Kraepelinian and non-Kraepelinian schizophrenia.
